podocalyxin-targeting mAb (ACTgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepodocalyxin-targeting mAb (ACTgen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesACTGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesACTGen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A